Accolade, Financial Statements From 2010 to 2026
| ACCDDelisted Stock | USD 7.02 0.00 0.00% |
Check Accolade, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Accolade,'s main balance sheet or income statement drivers, such as , as well as many indicators such as . Accolade, financial statements analysis is a perfect complement when working with Accolade, Valuation or Volatility modules.
Accolade, |
Accolade, Company Current Valuation Analysis
Accolade,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Accolade, Current Valuation | 588 M |
Most of Accolade,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Accolade, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Accolade, has a Current Valuation of 588 M. This is 95.91% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 96.46% higher than that of the company.
Accolade, Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accolade,'s current stock value. Our valuation model uses many indicators to compare Accolade, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accolade, competition to find correlations between indicators driving Accolade,'s intrinsic value. More Info.Accolade, is rated fifth in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Accolade, by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Accolade, Financial Statements
Accolade, stakeholders use historical fundamental indicators, such as Accolade,'s revenue or net income, to determine how well the company is positioned to perform in the future. Although Accolade, investors may analyze each financial statement separately, they are all interrelated. For example, changes in Accolade,'s assets and liabilities are reflected in the revenues and expenses on Accolade,'s income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Accolade,. Please read more on our technical analysis and fundamental analysis pages.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Accolade, Stock
If you are still planning to invest in Accolade, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accolade,'s history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets |